IGM BIOSCIENCES INC.

IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update

03 Nov 2022 08:05:00 By Nasdaq GlobeNewswire

IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma

02 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

IGM Biosciences to Present at Three Upcoming Investor Conferences

06 Sep 2022 06:00:01 By Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2022 Financial Results and Provides Corporate Update

08 Aug 2022 15:10:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2022 Jefferies Healthcare Conference

01 Jun 2022 06:00:01 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference

10 May 2022 06:00:01 By Nasdaq GlobeNewswire

IGM Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update

09 May 2022 15:16:43 By Nasdaq GlobeNewswire

IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi

06 May 2022 06:00:00 By Nasdaq GlobeNewswire

IGM Announces Closing of $230.0 Million Public Offering

06 Apr 2022 15:39:52 By Nasdaq GlobeNewswire

IGM Announces Pricing of $200.0 Million Public Offering

29 Mar 2022 23:56:16 By Nasdaq GlobeNewswire

IGM Announces Proposed Public Offering

29 Mar 2022 06:41:04 By Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

29 Mar 2022 05:01:00 By Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi

29 Mar 2022 01:00:03 By Nasdaq GlobeNewswire

IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment and Prevention of COVID-19

09 Feb 2022 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim 2022 Oncology Conference

03 Feb 2022 15:05:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

IGM Biosciences Presents Clinical Data from IGM-2323 in Patients with Advanced B Cell Malignancies at 2021 American Society of Hematology Annual Meeting

11 Dec 2021 12:31:32 By Nasdaq GlobeNewswire

IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria

08 Dec 2021 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 63rd Annual ASH Meeting

06 Dec 2021 15:05:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies London Healthcare Conference

10 Nov 2021 15:05:02 By Nasdaq GlobeNewswire